Skip Navigation
Search Menu
Find an Expert

 


Saleh Alqahtani, M.B.B.S.

Photo of Dr. Saleh Alqahtani, M.B.B.S.

Medical Director of International Digestive & Liver Services

Assistant Professor of Medicine

Male

Languages: English, Arabic

Expertise: Cirrhosis, Colon Polyps, Colonoscopy, Digestive Diseases, Endoscopy, Fatty Liver, Gastroenterology, Gastroesophageal Reflux Disease (GERD), Gastrointestinal Bleeding, Hepatitis B virus infection (HBV), Hepatitis C Virus infection (HCV), Indigestion, Liver Cancer, Liver Fibrosis, Liver Transplant , Pancreatic and Biliary Disease ...read more

Research Interests: Drug Induced Liver Injury; Liver Cancer; Hepatitis B; Hepatitis C; Fatty Liver Disease

Request an Appointment

I live in Maryland

410-933-7495
Request an appointment through MyChart!

I live outside of Maryland

410-464-6641
Request Appointment

I live outside of the United States

+1-410-502-7683
Request Appointment

Locations

The Johns Hopkins Hospital
Appointment Phone: 410-933-7495

600 N. Wolfe Street
Sheikh Zayed Tower
Baltimore, MD 21287 map
Phone: 410-955-3779

Johns Hopkins Outpatient Center
Appointment Phone: 410-933-7495

601 N. Caroline St.
Baltimore, MD 21287 map
Phone: 410-933-7495

Contact for Research Inquiries

720 Rutland Avenue
Ross Building, Suite 918
Baltimore, MD 21205 map

Background

Dr. Saleh Alqahtani is Director of Clinical Liver Research and Medical Director of International Digestive and Liver Disease Services at the Division of Gastroenterology and Hepatology at The Johns Hopkins Hospital.A highly regarded expert in liver and digestive diseases, endoscopy, and liver transplant, Dr. Alqahtani has been the principal investigator for clinical trials related to the management of fatty liver disease and viral hepatitis including novel agents. He also is the co-investigator for numerous clinical trials in liver cancer, liver cirrhosis, and outcome of liver transplantation.

The recipient of several awards and honors, Dr. Alqahtani has been an invited speaker both nationally and internationally, lecturing in Latin America, Asia, and Europe and has authored many publications and book chapters. Board Certified in transplant hepatology, gastroenterology, and internal medicine, Dr. Alqahtani is a member of professional societies including the American College of Gastroenterology, the Mayo Clinic Alumni Association, the American Association for the Study of Liver Diseases, the European Association for the Study of the Liver, and The Johns Hopkins Medical & Surgical Association.

Before coming to Johns Hopkins, Dr. Alqahtani served as Associate Director of the Gastroenterology Fellowship Program at the University of Texas Southwestern Medical Center in Dallas, Texas.  He also was an Instructor in Medicine at the Mayo Clinic in Rochester, Minnesota and faculty at Um Alqura University in Saudi Arabia.

Dr. Alqahtani earned his medical degree at King Abdulaziz University in Saudi Arabia, completed an internal medicine residency program at University of Western, performed a gastroenterology fellowship at the University of Calgary, and completed an advanced Liver diseases fellowship at the Mayo Clinic, Rochester, Minnesota.

...read more

Titles

  • Medical Director of International Digestive & Liver Services
  • Assistant Professor of Medicine

Departments / Divisions

Centers & Institutes

Education

Degrees

  • MBChB, King Abdul Aziz University (1999)

Residencies

  • University of Western Ontario / Internal Medicine (2004)

Fellowships

  • University of Calgary / Gastroenterology (2007)
  • Mayo Medical School College of Medicine (2008)

Board Certifications

  • American Board of Internal Medicine / Gastroenterology (2007)
  • American Board of Internal Medicine / Transplant Hepatology (2010)

Research & Publications

Clinical Trial Keywords

Hepatitis C, Fatty Liver, Liver Cancer, Liver Transplant

Clinical Trials

Fatty Liver, Hepatitis C, Hepatitis B, Liver cancer, Liver transplant, Liver failure, Cirrhosis

Selected Publications

Alqahtani SA, Watt K. Liver transplantation: Indications and patient selection. In Practical Gastroenterology and Hepatology. ISBN 978-1405182751. Wiley-Blackwell. 2010

Alqahtani SA, Larson AM, Liver transplantation for acute liver failure. In Liver transplantation. ISBN 978-953-51-0016-4, InTech, February 2012

Alqahtani SA. Sulkowski MS. Current and Evolving Treatments for Genotype 1 Hepatitis C Virus. Gastroenterology Clinics of North America. 2015 Dec;44(4):825-43

Alqahtani SA, Coffin CS, Burak KW, Chen F, MacGregor J, Beck P. Hepatic portal venous gas: a report of two cases and a review of the epidemiology, pathogenesis, diagnosis and approach to management. Canadian J of Gastroenterology. 2007 May; 21(5):309-13.

Alqahtani SA, Federico P, Myers RP. A case of valproate-induced hyperammonemic encephalopathy: look beyond the liver. Canadian Medical Association Journal. 2007 Sep 11; 177(6):568-9.

Asfaha S, Alqahtani SA, Maclean T, Hilsden B, Beck PB. Assessment of Endoscopic Training of General Surgery Residents in a North American Health Region. Gastrointestinal Endoscopy. 2008 Dec; 68(6): 1056-62.

Federico P, Alqahtani SA, Myers RP. Possible new clinical sign of hyperammonemia. Canadian Medical Association Journal. 2008 Jan 29; 178 (3).

Alqahtani SA. Hepatitis C, What Clinicians need to know? Canadian Journal of Diagnosis. 2008 Jan 1. P: 72-76

Alqahtani SA, Lee SS, Cirrhotic Cardiomyopathy, Seminars in Liver Disease Journal. 2008, Feb, 28(1): 59-69

Alqahtani SA, Sanchez W. Statins Are Safe for the Treatment of Hypercholestrolemia in Patients with Chronic Liver Disease. Gastroenterology Journal. 2008 July 8

Alhamoudi WK, Alqahtani SA, Ma M, Lee SS. Hemodynamic in the Immediate Postoperative Period after Liver Transplantation in Alcoholic and Post-viral Cirrhosis. World J Gastroenterol. 2010 Feb 7; 16(5): 608-12.

Alhamoudi W, Mohamed H, Abaalkhail F, Kamel Y, Almasiro N, Allam N, Alqahtani SA, Alosofyan M, Khalaff H, Alsebeyel M, Aljedai A, Abdo A. Treatment of Genotype-4 Hepatitis C Recurring After Liver Transplantation Using a Combination of Pegylated Interferon Alfa-2a and Ribavirin. Digestive Diseases and Sciences Journal, 2011 Jan 8.

Alqahtani SA, Larson AM. Adult Liver transplantation in the USA. Curr Opin Gastroenterology. 2011 May; 27(3): 240-7

Alqahtani SA. Update in Liver transplantation. Current opinion in Gastroenterology, Curr Opin Gastroenterol. 2012 May; 28 (3): 230-8.

Alqahtani SA. Update in Liver transplantation. Discov Med. 2012 Aug; 14(75):133-41.

Al-Hamoudi W, Ali S, Hegab B, Elsiesy H, Hashim A, Al-Sofayan M, Khalaf H, Al-Bahili H, Al-Masri N, Al-Sebayel M, Broering D, Abdo A, Alqahtani SA, Abaalkhail F. Revising the upper limit of normal for levels of serum alanine aminotransferase in a middle eastern population with normal liver histology. Dig Dis Sci. 2013 Aug; 58(8):2369-75

Singal AG, Dharia TD, Malet PF, Alqahtani SA, Zhang S, Cuthbert JA. Long-term benefit of hepatitis C therapy in a safety net hospital system: a cross-sectional study with median 5-year follow-up. BMJ Open, 2013 Sep 3;3(9)

Woreta T, Alqahtani SA, Evaluation of Abnormal Liver Tests. Medical Clinics of North America Journal. 2014 Jan;98(1):1-16

Alqahtani SA, Kleiner DE, Ghabril M, Gu J, Hoofnagle JH, Rockey DC; DILIN study investigators Identification and Characterization of Cefazolin-induced Liver Injury. Clin Gastroenterol Hepatol. 2015 Jul;13(7):1328-1336.e2. doi: 10.1016/j.cgh.2014.11.036.

Alqahtani SA, Afdhal N, Zeuzem S, Gordon S, Mangia A, Kwo P, Fried M, Yang JC, Ding X, Pang PS, McHutchison JG, Pound D, Reddy KR, Marcellin P, Kowdley KV, Sulkowski M. Safety and Tolerability of Ledipasvir/Sofosbuvir with and without Ribavirin in Patients with Chronic HCV Genotype 1 Infection: Analysis of Phase 3 ION trials. Hepatology. 2015 Jul;62(1):25-30. doi: 10.1002/hep.27890

Dhingra A, Kapoor S, Alqahtani SA, Recent advances in the treatment of hepatitis C.Discov Med. 2014 Oct;18(99):203-8.

Videos & Media

Hepatitis C - What You Need To Know

Saleh Alqahtani, MD, Assistant Professor of Medicine, Johns Hopkins Gastroenterology & Hepatology, discusses what you need to know about Hepatitis C. For more information: http://www.hopkinsmedicine.org/gi

Recent News Articles and Media Coverage

New Therapy for Hepatitis C, Inside Tract, July 5, 2013 

Is this you? Edit Profile